Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers

A Multi-Center, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.

Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers

Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers

Affinity Prospective Diabetic Foot Trial Crossover Group